BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29611250)

  • 1. Differences in the prevalence of sarcopenia in haemodialysis patients: the effects of gender and ethnicity.
    Yoowannakul S; Tangvoraphonkchai K; Vongsanim S; Mohamed A; Davenport A
    J Hum Nutr Diet; 2018 Oct; 31(5):689-696. PubMed ID: 29611250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the prevalence of sarcopenia in peritoneal dialysis patients using hand grip strength and appendicular lean mass: depends upon guideline definitions.
    Abro A; Delicata LA; Vongsanim S; Davenport A
    Eur J Clin Nutr; 2018 Jul; 72(7):993-999. PubMed ID: 29921962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Prevalence of Muscle Weakness (Sarcopenia) in Haemodialysis Patients Determined by Hand Grip Strength Due to Variation in Guideline Definitions of Sarcopenia.
    Tangvoraphonkchai K; Hung R; Sadeghi-Alavijeh O; Davenport A
    Nutr Clin Pract; 2018 Apr; 33(2):255-260. PubMed ID: 29377324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Sarcopenia and Relationships Between Muscle and Bone in Indian Men and Women.
    Zengin A; Kulkarni B; Khadilkar AV; Kajale N; Ekbote V; Tandon N; Bhargava SK; Sachdev HS; Sinha S; Scott D; Kinra S; Fall CHD; Ebeling PR
    Calcif Tissue Int; 2021 Oct; 109(4):423-433. PubMed ID: 33966094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of muscle wasting (sarcopenia) in peritoneal dialysis patients varies with ethnicity due to differences in muscle mass measured by bioimpedance.
    Yoowannakul S; Tangvoraphonkchai K; Davenport A
    Eur J Clin Nutr; 2018 Mar; 72(3):381-387. PubMed ID: 29158495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis Patients.
    Slee A; McKeaveney C; Adamson G; Davenport A; Farrington K; Fouque D; Kalantar-Zadeh K; Mallett J; Maxwell AP; Mullan R; Noble H; O'Donoghue D; Porter S; Seres DS; Shields J; Witham M; Reid J
    J Ren Nutr; 2020 Jul; 30(4):313-321. PubMed ID: 31734056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults.
    Scott D; Hayes A; Sanders KM; Aitken D; Ebeling PR; Jones G
    Osteoporos Int; 2014 Jan; 25(1):187-93. PubMed ID: 23800748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement and Predictive Validity Using Less-Conservative Foundation for the National Institutes of Health Sarcopenia Project Weakness Cutpoints.
    Chiles Shaffer N; Ferrucci L; Shardell M; Simonsick EM; Studenski S
    J Am Geriatr Soc; 2017 Mar; 65(3):574-579. PubMed ID: 28024092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence-based comparison of operational criteria for the presence of sarcopenia.
    Dam TT; Peters KW; Fragala M; Cawthon PM; Harris TB; McLean R; Shardell M; Alley DE; Kenny A; Ferrucci L; Guralnik J; Kiel DP; Kritchevsky S; Vassileva MT; Studenski S
    J Gerontol A Biol Sci Med Sci; 2014 May; 69(5):584-90. PubMed ID: 24737561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agreement and diagnostic differences among three definitions of sarcopenia in patients with chronic hepatitis C.
    de Vries TP; Pires AM; Diniz KGD; Chagas ALS; Vieira DA; Kakehasi AM; Suen VMM; Bering T; Colosimo EA; Rocha GA; de Paula Farah K; Silva LD
    Nutr Clin Pract; 2024 Jun; 39(3):568-578. PubMed ID: 38445969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia Definitions and Their Associations With Mortality in Older Australian Women.
    Sim M; Prince RL; Scott D; Daly RM; Duque G; Inderjeeth CA; Zhu K; Woodman RJ; Hodgson JM; Lewis JR
    J Am Med Dir Assoc; 2019 Jan; 20(1):76-82.e2. PubMed ID: 30527277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.
    McLean RR; Shardell MD; Alley DE; Cawthon PM; Fragala MS; Harris TB; Kenny AM; Peters KW; Ferrucci L; Guralnik JM; Kritchevsky SB; Kiel DP; Vassileva MT; Xue QL; Perera S; Studenski SA; Dam TT
    J Gerontol A Biol Sci Med Sci; 2014 May; 69(5):576-83. PubMed ID: 24737560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Skeletal muscle function deficit" in a nationally representative British birth cohort in early old age.
    Cooper R; Bann D; Wloch EG; Adams JE; Kuh D
    J Gerontol A Biol Sci Med Sci; 2015 May; 70(5):604-7. PubMed ID: 25431354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Sarcopenia Employing Population-Specific Cut-Points: Cross-Sectional Data from the Geelong Osteoporosis Study, Australia.
    Sui SX; Holloway-Kew KL; Hyde NK; Williams LJ; Tembo MC; Leach S; Pasco JA
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of sarcopenia and relationships between muscle and bone in ageing West-African Gambian men and women.
    Zengin A; Jarjou LM; Prentice A; Cooper C; Ebeling PR; Ward KA
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):920-928. PubMed ID: 30221478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia diagnosis in patients receiving hemodialysis: Agreement among different consensuses.
    Rosa CSC; Ribeiro HS; Vogt BP; Sakkas GK; Monteiro HL
    Nutr Clin Pract; 2022 Dec; 37(6):1348-1355. PubMed ID: 34970778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients.
    Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG
    BMC Nephrol; 2019 Feb; 20(1):54. PubMed ID: 30764799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of pre-sarcopenia and sarcopenia in Hong Kong Chinese geriatric patients with hip fracture and its correlation with different factors.
    Ho AW; Lee MM; Chan EW; Ng HM; Lee CW; Ng WS; Wong SH
    Hong Kong Med J; 2016 Feb; 22(1):23-9. PubMed ID: 26680156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia in chronic kidney disease: prevalence by different definitions and relationship with adiposity.
    Bellafronte NT; GovĂȘia TR; Chiarello PG
    Appl Physiol Nutr Metab; 2022 Sep; 47(9):915-925. PubMed ID: 35658617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia and relationships between muscle mass, measured glomerular filtration rate and physical function in patients with chronic kidney disease stages 3-5.
    Zhou Y; Hellberg M; Svensson P; Höglund P; Clyne N
    Nephrol Dial Transplant; 2018 Feb; 33(2):342-348. PubMed ID: 28340152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.